Marc D Piroth
Overview
Explore the profile of Marc D Piroth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
1229
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borm K, Behzadi S, Horner-Rieber J, Krug D, Baumann R, Corradini S, et al.
Strahlenther Onkol
. 2024 Mar;
200(4):259-275.
PMID: 38488902
Purpose: The aim of this review was to evaluate the existing evidence for radiotherapy for brain metastases in breast cancer patients and provide recommendations for the use of radiotherapy for...
2.
Degener S, Schmalz O, Tosch M, Godde D, von Rundstedt F, Piroth M
Z Gerontol Geriatr
. 2023 Jun;
56(4):324-334.
PMID: 37306771
Prostate cancer is the most frequent cancer in men. For localized prostate cancer, surgery and radiotherapy are the standard treatment, with active surveillance also used in low-risk cases. For advanced/metastatic...
3.
Piroth M, Krug D, Feyer P, Baumann R, Combs S, Duma M, et al.
Strahlenther Onkol
. 2022 May;
198(7):601-611.
PMID: 35527272
Evidence from a few small randomized trials and retrospective cohorts mostly including various tumor entities indicates a prolongation of disease free survival (DFS) and overall survival (OS) from local ablative...
4.
Piroth M, Strnad V, Krug D, Fastner G, Baumann R, Combs S, et al.
Breast Care (Basel)
. 2022 Mar;
17(1):81-84.
PMID: 35355706
Background: During the last decade, partial breast irradiation (PBI) has gained traction as a relevant treatment option for patients with early-stage low-risk breast cancer after breast-conserving surgery. The TARGIT-A prospective...
5.
Piroth M, Draia S, Jawad J, Piefke M
Strahlenther Onkol
. 2022 Mar;
198(4):388-396.
PMID: 35238982
Purpose: It is known that the diagnosis of breast cancer often causes anxiety and depression. Radiotherapy of the breast as an obligatory part of a breast-conserving treatment concept can markedly...
6.
Piroth M, Krug D, Fastner G, Sedlmayer F, Budach W
Strahlenther Onkol
. 2021 Apr;
197(6):558-559.
PMID: 33891127
No abstract available.
7.
Krug D, Baumann R, Combs S, Duma M, Dunst J, Feyer P, et al.
Strahlenther Onkol
. 2021 Jan;
197(4):269-280.
PMID: 33507331
Moderate hypofractionation is the standard of care for adjuvant whole-breast radiotherapy after breast-conserving surgery for breast cancer. Recently, 10-year results from the FAST and 5‑year results from the FAST-Forward trial...
8.
Piroth M, Krug D, Sedlmayer F, Duma M, Baumann R, Budach W, et al.
Strahlenther Onkol
. 2020 Aug;
197(1):1-7.
PMID: 32737515
Purpose: Following neoadjuvant chemotherapy for breast cancer, postoperative systemic therapy, also called post-neoadjuvant treatment, has been established in defined risk settings. We reviewed the evidence for sequencing of postoperative radiation...
9.
Krug D, Baumann R, Budach W, Duma M, Dunst J, Feyer P, et al.
Breast Care (Basel)
. 2020 May;
15(2):118-126.
PMID: 32398980
Background: Gene expression assays are increasingly used for decision-making regarding adjuvant chemotherapy in patients with hormone receptor-positive, HER2-negative breast cancer. There are some clinical situations in which there is also...
10.
Hehr T, Baumann R, Budach W, Duma M, Dunst J, Feyer P, et al.
Strahlenther Onkol
. 2019 Aug;
195(11):949-963.
PMID: 31451835
Background: Skin-sparing (SSME) and nipple-sparing mastectomy (NSME) were developed to improve the cosmetic results for breast cancer (BC) patients, both allowing for immediate breast reconstruction. Recommendations for post-mastectomy radiotherapy (PMRT)...